Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerald C Sadoff

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
American Journal of Respiratory and Critical Care Medicine|January 12, 2013
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adultsCheryl L Day, Michele Tameris, Nazma Mansoor, et al.
Vaccine|July 20, 2002
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy childrenYu-Lung Lau, S J Rupert Vessey, Ivan S F Chan, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2017
Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized TrialRichard N van Zyl-Smit, Aliasgar Esmail, Mary E Bateman, et al.
American Journal of Respiratory and Critical Care Medicine|February 20, 2010
The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adultsBrian Abel, Michele Tameris, Nazma Mansoor, et al.
Vaccine|September 15, 2014
The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responsesBenjamin M N Kagina, Michele D Tameris, Hennie Geldenhuys, et al.
Nature|January 6, 2012
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysDan H Barouch, Jinyan Liu, Hualin Li, et al.
AIDS Research and Human Retroviruses|February 1, 2007
Evaluation of cellular immune responses in subjects chronically infected with HIV type 1Tong-Ming Fu, Sheri A Dubey, Devan V Mehrotra, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
American Journal of Respiratory and Critical Care Medicine|January 12, 2013
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adultsCheryl L Day, Michele Tameris, Nazma Mansoor, et al.
Vaccine|July 20, 2002
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy childrenYu-Lung Lau, S J Rupert Vessey, Ivan S F Chan, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2017
Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized TrialRichard N van Zyl-Smit, Aliasgar Esmail, Mary E Bateman, et al.
American Journal of Respiratory and Critical Care Medicine|February 20, 2010
The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adultsBrian Abel, Michele Tameris, Nazma Mansoor, et al.
Vaccine|September 15, 2014
The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responsesBenjamin M N Kagina, Michele D Tameris, Hennie Geldenhuys, et al.
Nature|January 6, 2012
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysDan H Barouch, Jinyan Liu, Hualin Li, et al.
AIDS Research and Human Retroviruses|February 1, 2007
Evaluation of cellular immune responses in subjects chronically infected with HIV type 1Tong-Ming Fu, Sheri A Dubey, Devan V Mehrotra, et al.
Pageof 3